By activating the immune system within the tumor, the road ahead for patients is paved with possibility.
Learn More– Objective Response Rate Endpoint Not Met – EXTON, Pa. , March 18, 2021 (GLOBE NEWSWIRE) --… Read more
ILLUMINATE-301 Continues on Track for Data Later this Month EXTON, Pa. , March 01, 2021 (GLOBE… Read more
EXTON, Pa. , Jan. 11, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today… Read more